Post‐COVID 19 neurological syndrome: A new risk factor that modifies the prognosis of patients with dementia
Open Access
- 5 September 2021
- journal article
- letter
- Published by Wiley in Alzheimer's & Dementia
- Vol. 18 (3), 542-543
- https://doi.org/10.1002/alz.12459
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Acute and Post-Acute Neurological Complications of COVID-19Neurology International, 2021
- Spectrum of neurologic & neuroimaging manifestation in COVID-19Brain, Behavior, & Immunity - Health, 2021
- COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the USAlzheimer's & Dementia, 2021
- The effects of the COVID-19 pandemic on people with dementiaNature Reviews Neurology, 2021
- The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioningAlzheimer's & Dementia, 2021
- Letter to the editor. Healthcare workers on the edge of sanity due to COVID-19: Rapid review of the results of systematic reviews and meta-analyzesJournal of Clinical Neuroscience, 2020
- Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology communityJournal of the Neurological Sciences, 2020
- Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cellsJournal of NeuroVirology, 2020
- Immediate and long-term consequences of COVID-19 infections for the development of neurological diseaseAlzheimer's Research & Therapy, 2020